comprehensive -WSS

comprehensive

author：leisure time 2025-10-01 23:03:02 - browse：5

Have you ever taken phenylephrine for a stuffed-up nose and then felt better? If so, you might have been perplexed when Food and Drug Administration experts recently said that that the drug — which is in some versions of DayQuil, Sudafed, and other medicines — is no more effective than a placebo.

But to Michael H. Bernstein, an assistant professor of diagnostic imaging at the Warren Alpert Medical School of Brown University, it all makes sense. Bernstein says that “no better than a placebo” still means that it works, sort of. “If we expect to feel better, then we probably will,” he told me. And that complicates the idea of what medical treatment “works.”

On this episode of the “First Opinion Podcast,” we discuss the placebo effect and its counterpart, the “nocebo effect” — if you tell patients something will make them feel worse, it generally comes true. “You’re better off hearing from a doctor something to the effect of 3 out of 4 patients who take this drug have no side effects at all versus 25% of people who take this drug do get side effects,” he said.

Bernstein also shared the delightful story of how he got into the “medical expectations” field, which started with an experiment in which he had to convince underage students that they were drinking alcohol when they weren’t.

Our conversation was based on a First Opinion Bernstein recently wrote with Grayson L. Baird, “Phenylephrine is no better than a placebo. What if that’s still better than nothing?”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts.

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： How AI helped researchers track recovery from depression

knowledge

WSS

Bird flu outbreak in cows is latest avian flu curveball

What Congress can do to address the rural doctor shortage

Intarcia’s device

How AI helped researchers track recovery from depression

Experts study whether long Covid risk adds up with each reinfection

Readout LOUD podcast: What to know about H5N1 bird flu

focus

comprehensive

leisure time

Medicare details structure of new drug price negotiation program

Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

Dobbs anniversary: the lost opportunity of abortion as health care

Senators: Long

Wildfire smoke exposes gaps in outdoor worker protections

Senators: Long

Medicare proposal to cover medical devices draws a mixed reaction

CDC wastewater surveillance dashboard to track bird flu hotspots

Novavax promises a turnaround & Lilly roils the obesity market

Google says AlphaFold 3 can map a vast universe of biomolecules

hotspot

Biotech stock slump in 2023: awaiting the turnaround

Making AI in medicine accessible to smaller, and rural hospitals

After gene therapy, two congenitally deaf children hear for the first time

Telehealth startups turn to complex chronic diseases

How to improve immunocompromised access to mAb treatments

Lasker Awards 2023: Winners in biomedical research

Wikipedia

leisure time

knowledge

explore